Herein, we applied AUY922, a well‐known N‐terminal HSP90 inhibitor (with IC50 values of 7.8 and 21 nM for HSP90α and HSP90β) for its anti‐tumor property in IMQ‐induced psoriasis mouse model. Here, HSP90AA1 is linked to neoplasm.